Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Plasmanate Market Forecast: What Market Value Is Expected By 2030?
The historic period’s expansion was driven by a wider range of surgical interventions necessitating volume replacement, alongside the accessibility of plasma fractionation methods. An increasing number of trauma and burn treatment cases played a role, as did the utilization of therapies based on albumin. Furthermore, the proliferation of hospital critical care units contributed to this growth.
The forecast period’s expansion is driven by a heightened need for safer plasma-derived products, greater investments in plasma collection infrastructure, the broadening of emergency and trauma care services, an intensified focus on protein-based therapeutics, and progress in plasma processing technologies. Key developments shaping this period encompass the growing adoption of plasma protein volume expanders, an uptick in demand for blood-derived therapeutics, a stronger emphasis on safe and pasteurized plasma products, the widening scope of critical care applications, and an increased priority on supply chain traceability.
Download A Free Sample Report For Comprehensive Market Insights:
Plasmanate Market Industry Drivers: What Is Driving Revenue Growth?
The anticipated rise in trauma cases is set to drive forward the expansion of the plasmanate market. Trauma cases encompass severe physical or psychological injuries resulting from external forces or distressing events, necessitating urgent medical intervention, surgical procedures, rehabilitation, and psychological care for recovery. This increase in trauma incidents is linked to higher accident frequencies, urbanization that heightens exposure to dangerous conditions, and lifestyle shifts like greater risk-taking behaviors and substance misuse. Trauma patients may experience hypovolemic shock from substantial blood loss, where plasma transfusion becomes vital for restoring blood volume and stabilizing blood pressure. For example, in 2025, the Wisconsin Department of Health Services (DHS), a state government health agency in the U.S., reported that trauma cases in Wisconsin grew by approximately 5.6% between 2023 and 2024. Consequently, the growing number of trauma cases is fueling the plasmanate market’s growth.
Plasmanate Market Driver: The Impact Of Rising Autoimmune Disease Prevalence On The Growth Of The Market
The growing frequency of autoimmune diseases is expected to boost the plasmanate market in the future. Autoimmune diseases arise when the immune system erroneously attacks the body’s own healthy cells, tissues, and organs, treating them as foreign threats. This rise in autoimmune conditions is due to several factors, such as enhanced awareness and diagnostic capabilities, genetic susceptibilities, and environmental elements like pollutants, dietary shifts, and lifestyle habits. Plasmanate is employed in autoimmune diseases to replenish plasma volume and maintain hemodynamic stability, aiding patients during immune-related emergencies. As an illustration, in July 2024, the National Health Service (NHS) England, a UK government department, noted that multiple sclerosis impacts over 150,000 individuals in the UK, with more than 120,000 in England, and is more common among women. Around 135 new diagnoses occur each week, underscoring its substantial effect on the population. Thus, the increasing prevalence of autoimmune diseases is driving plasmanate market growth.
Plasmanate Market Driver: Rising Chronic Illnesses Expected To Increase Demand For Plasmanate In Healthcare
The escalating occurrence of chronic illnesses is predicted to broaden the plasmanate market in the years ahead. Chronic illnesses are enduring health conditions that last for a year or longer and often require continuous medical care or restrict daily activities. This rise in chronic diseases is fueled by factors like greater exposure to risk elements such as obesity, hypertension, and unhealthy lifestyles, combined with aging populations and environmental factors that foster non-communicable diseases. Plasmanate is applied in chronic conditions to restore plasma volume and address hypoproteinemia in cases like liver disease, severe burns, or nephrotic syndrome. For instance, in 2025, the Northern Arizona Medical Group, a U.S.-based healthcare provider, stated that nearly three-quarters of the global population is expected to have at least one chronic illness, with prevalence continuing to climb notably. In the United States during 2023, around 76.4% of adults reported having at least one chronic condition, and 51.4% had two or more. Therefore, the rising prevalence of chronic illnesses is propelling the plasmanate market’s growth.
Plasmanate Market Segmentation: How Is The Market Structured Across Key Categories?
The plasmanate market covered in this report is segmented –
1) By Formulation: Liquid Formulations, Lyophilized Formulations
2) By Clinical Indication: Hypovolemia, Burns, Shock, Hypoproteinemia, Surgical Procedures
3) By Distribution Channel: Online Pharmacies, Wholesale Distributors
4) By End User: Hospitals, Clinical Research Laboratories
Plasmanate Market Competitive Landscape And Leading Companies
Major companies operating in the plasmanate market are Grifols Therapeutics LLC
Access The Complete Plasmanate Market Report:
Plasmanate Market Leading Geography: Which Region Generates The Most Revenue?
North America was the largest region in the plasmanate market in 2025. The regions covered in the plasmanate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model